Understanding eosinophil behavior in rare blood and tissue conditions
Part of Blood & lymphatic, Immune system & allergy, Infections, Lungs & breathing clinical trials.
This research study examines how eosinophils (a type of white blood cell) behave and function when they become abnormally high in the blood or tissues. Researchers want to understand these conditions better to potentially improve treatment options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be willing to follow all study procedures and be available for the full duration
- You must be between ages 1 and 100
- You (or your legal guardian) must be able to understand and sign a consent form
- You must have either very high eosinophil counts in your blood, abnormal eosinophils in your skin or tissues, or suspected organ involvement from eosinophils
- You must have a primary doctor outside of the National Institutes of Health for your routine care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows families with a genetic condition that causes high levels of white blood cells called eosinophils. Researchers want to understand how the disease develops and changes over time to help predict who may get worse and how to treat it better.
This study follows people with or suspected Hyper-IgE syndrome (a rare immune disorder causing repeated infections and skin problems) to understand how the condition develops, how best to manage it, and which genes are involved. Researchers also welcome healthy relatives of patients to help identify genetic patterns.
This study follows people with long-term high eosinophils (a type of white blood cell) and related conditions to learn how the illness changes over time. It helps doctors understand patterns of organ involvement and outcomes, which may improve future care.
This study looks at different types of eosinophils (a type of white blood cell) in people with asthma, EGPA, or HES. It aims to help doctors better understand these conditions and could guide future treatments.
This study looks at how eosinophils (a type of white blood cell) work in asthma, including in people who have not responded to certain biologic treatments. By joining, you may help researchers understand asthma better and potentially improve future treatments.
This study looks at how a type of white blood cell (eosinophil) works differently in people with eosinophilic lung diseases. It may help doctors understand these conditions better and find new treatments.
Hear when a new Immune System Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.